Torys LLP
Toronto416.865.0040 New York212.880.6000 Calgary403.776.3700 Montréal514.868.5600

Practice Areas and Industry Groups

Life Sciences 

Torys' approach differs significantly because it leverages the experience of its U.S. life sciences lawyers based in New York. Torys brings unique experiences and techniques. (Lexpert)

Our Life Sciences Practice is recognized internationally for our leadership in advising the sector, including in publications by Lexpert/American Lawyer Media, Practical Law Company and Chambers & Partners.

Our practice assists clients in the application and commercialization of scientific research, in determining appropriate business structures, and in implementing business and financial plans and financing arrangements. Our clients include Canadian, U.S. and international researchers, developers, manufacturers, sellers and distributors of products in the areas of biotechnology, diagnostics, therapeutics, agriculture, medical devices, drug discovery and development, natural health products, consumer products and healthcare. We also regularly represent universities, hospitals, research institutes and health organizations, as well as investors. We represent 14 of the world's top 20 pharmaceutical and biotechnology companies, ranked by healthcare revenue.

Our services include advice on

  • corporate finance, M&A and general corporate matters, including tax incentives related to conducting research in Canada
  • regulatory compliance and marketing, including advice on regulatory, advertising and pricing issues; compliance for companies whose conduct is regulated by the Food and Drugs Act; trade, pricing and cross-border issues associated with the sale of drugs over the Internet
  • protection and commercial exploitation of intellectual property rights, including ongoing strategy and management of patents and trademarks, including those related to software and business methods used in the collection and use of data, diagnostics and other pharma-related services
  • issues arising in connection with research and clinical trials
  • privacy issues regarding the collection and use of data
  • public and private reimbursement (through formularies) for drugs under applicable laws
  • technology contracting, including outsourcing and licensing
  • partnerships, joint ventures and strategic alliances
  • litigation, dispute resolution and arbitration of business and intellectual property disputes